Katrien Berns
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Research top 5%
Papers in
-
- Protein Degradation and Inhibitors 5
- Chromatin Remodeling and Cancer 4
- Ubiquitin and proteasome pathways 3
- Oncology 7
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- René Bernards (17 shared papers)Roderick L. Beijersbergen (10 shared papers)E. Marielle Hijmans (8 shared papers)Mandy Madiredjo (4 shared papers)Jasper Mullenders (5 shared papers)Marc J. van de Vijver (2 shared papers)Hugo M. Horlings (2 shared papers)Michael Hauptmann (2 shared papers)
- Journals
- Oncogene (4 papers)Cancer Research (3 papers)Nature Cell Biology (2 papers)Molecular Cancer Therapeutics (1 paper)The EMBO Journal (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Katrien Berns
19 papers receiving 2.9k citations
Katrien Berns's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 1.2k
- Cancer Research 537
- Molecular Biology 2.2k
- Aging 33
- Radiology, Nuclear Medicine and Imaging 417
Countries citing papers authored by Katrien Berns
This map shows the geographic impact of Katrien Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Berns more than expected).
Fields of papers citing papers by Katrien Berns
This network shows the impact of papers produced by Katrien Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Berns. The network helps show where Katrien Berns may publish in the future.
Co-authors
The 25 scholars most cited alongside Katrien Berns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer Hit paper breakdown → | 2007 | 1236 |
| 2 | A large-scale RNAi screen in human cells identifies new components of the p53 pathway Hit paper breakdown → | 2004 | 850 |
| 3 | 2005 | 220 | |
| 4 | 1997 | 98 | |
| 5 | 2005 | 85 | |
| 6 | 2018 | 77 | |
| 7 | 2018 | 71 | |
| 8 | 2004 | 70 | |
| 9 | 2008 | 65 | |
| 10 | 2015 | 61 | |
| 11 | 2000 | 52 | |
| 12 | 2012 | 31 | |
| 13 | 2000 | 24 | |
| 14 | 2009 | 17 | |
| 15 | 2004 | 15 | |
| 16 | 2022 | 9 | |
| 17 | 2009 | 4 | |
| 18 | 2017 | 2 | |
| 19 | 2017 | 1 |
About Katrien Berns
Katrien Berns is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Cancer Mechanisms and Therapy (5 papers), Chromatin Remodeling and Cancer (4 papers), Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), HER2/EGFR in Cancer Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (537 citations), Molecular Biology (2.2k citations), Aging (33 citations) and Radiology, Nuclear Medicine and Imaging (417 citations). Katrien Berns has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include René Bernards, Roderick L. Beijersbergen, E. Marielle Hijmans, Mandy Madiredjo, Jasper Mullenders, Marc J. van de Vijver, Hugo M. Horlings, Michael Hauptmann, Bryan T. Hennessy and Ana M. González-Angulo. Their work appears in journals such as Oncogene, Cancer Research, Nature Cell Biology, Molecular Cancer Therapeutics and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.